KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Capital Expenditures (2016 - 2026)

Historic Capital Expenditures for Silicon Laboratories (SLAB) over the last 18 years, with Q1 2026 value amounting to $10.0 million.

  • Silicon Laboratories' Capital Expenditures rose 15182.94% to $10.0 million in Q1 2026 from the same period last year, while for Jan 2026 it was $29.9 million, marking a year-over-year increase of 15469.87%. This contributed to the annual value of $29.9 million for FY2026, which is 15469.87% up from last year.
  • As of Q1 2026, Silicon Laboratories' Capital Expenditures stood at $10.0 million, which was up 15182.94% from $6.4 million recorded in Q4 2025.
  • In the past 5 years, Silicon Laboratories' Capital Expenditures ranged from a high of $15.0 million in Q1 2022 and a low of $2.0 million during Q1 2024
  • For the 5-year period, Silicon Laboratories' Capital Expenditures averaged around $6.2 million, with its median value being $5.8 million (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 7326.63% in 2024, then soared by 18953.8% in 2025.
  • Over the past 5 years, Silicon Laboratories' Capital Expenditures (Quarter) stood at $6.5 million in 2022, then tumbled by 42.04% to $3.7 million in 2023, then rose by 5.71% to $4.0 million in 2024, then skyrocketed by 61.32% to $6.4 million in 2025, then surged by 56.11% to $10.0 million in 2026.
  • Its Capital Expenditures stands at $10.0 million for Q1 2026, versus $6.4 million for Q4 2025 and $8.7 million for Q3 2025.